Ontology type: schema:ScholarlyArticle
2022-04-01
AUTHORS ABSTRACTBackgroundPlatelet rich plasma (PRP) injections have been reported to be an effective and low side effect treatment for androgenetic alopecia (AGA). However, robust data concerning this therapy are lacking.AimWe address some potentially critical aspects of PRP treatment and give some reasons why study results may differ.Materials and methodsIn the following review we give a brief overview of the current literature and compare the results of the various trials.ResultsIn recent years, several clinical trials have been published that have revealed different but rather positive results, which offers hope to those affected by AGA and to physicians as well. However, the results were observed in methodologically weak trials and data from randomized controlled trials are lacking. Differences in trial designs have made it difficult to draw concrete conclusions about its clinical efficacy. Even in the studies where no hair-growth-promoting effect could be observed, the majority of subjects were at least satisfied with the result. The combination of several treatment approaches seems to lead to optimal improvement in hair growth.ConclusionThere are many factors that could have influenced the results of the different studies. The results were observed in methodologically weak studies, giving reason for caution when drawing conclusions. Nevertheless, the majority of the subjects were at least satisfied with the result. Given the current low level of evidence, PRP treatments need to be further investigated in larger studies. More... »
PAGES353-357
http://scigraph.springernature.com/pub.10.1007/s00105-022-04979-6
DOIhttp://dx.doi.org/10.1007/s00105-022-04979-6
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1146807082
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/35364687
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Alopecia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Platelet-Rich Plasma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Universit\u00e4tsklinik f\u00fcr Dermatologie und Venerologie, Medizinische Universit\u00e4t Graz, Auenbruggerplatz\u00a08, 8036, Graz, \u00d6sterreich",
"id": "http://www.grid.ac/institutes/grid.411580.9",
"name": [
"Universit\u00e4tsklinik f\u00fcr Dermatologie und Venerologie, Medizinische Universit\u00e4t Graz, Auenbruggerplatz\u00a08, 8036, Graz, \u00d6sterreich"
],
"type": "Organization"
},
"familyName": "Gressenberger",
"givenName": "P.",
"id": "sg:person.014432353047.59",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014432353047.59"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Universit\u00e4tsklinik f\u00fcr Dermatologie und Venerologie, Medizinische Universit\u00e4t Graz, Auenbruggerplatz\u00a08, 8036, Graz, \u00d6sterreich",
"id": "http://www.grid.ac/institutes/grid.411580.9",
"name": [
"Universit\u00e4tsklinik f\u00fcr Dermatologie und Venerologie, Medizinische Universit\u00e4t Graz, Auenbruggerplatz\u00a08, 8036, Graz, \u00d6sterreich"
],
"type": "Organization"
},
"familyName": "Kopera",
"givenName": "D.",
"id": "sg:person.01157615045.78",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157615045.78"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s12020-017-1280-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1084033726",
"https://doi.org/10.1007/s12020-017-1280-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00403-020-02173-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1134505309",
"https://doi.org/10.1007/s00403-020-02173-z"
],
"type": "CreativeWork"
}
],
"datePublished": "2022-04-01",
"datePublishedReg": "2022-04-01",
"description": "BackgroundPlatelet rich plasma (PRP) injections have been reported to be an effective and low side effect treatment for androgenetic alopecia (AGA). However, robust data concerning this therapy are lacking.AimWe address some potentially critical aspects of PRP treatment and give some reasons why study results may differ.Materials and methodsIn the following review we give a\u00a0brief overview of the current literature and compare the results of the various trials.ResultsIn recent years, several clinical trials have been published that have revealed different but rather positive results, which offers hope to those affected by AGA and to physicians as well. However, the results were observed in methodologically weak trials and data from randomized controlled trials are lacking. Differences in trial designs have made it difficult to draw concrete conclusions about its clinical efficacy. Even in the studies where no hair-growth-promoting effect could be observed, the majority of subjects were at least satisfied with the result. The combination of several treatment approaches seems to lead to optimal improvement in hair growth.ConclusionThere are many factors that could have influenced the results of the different studies. The results were observed in methodologically weak studies, giving reason for caution when drawing conclusions. Nevertheless, the majority of the subjects were at least satisfied with the result. Given the current low level of evidence, PRP treatments need to be further investigated in larger studies.",
"genre": "article",
"id": "sg:pub.10.1007/s00105-022-04979-6",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1327382",
"issn": [
"0017-8470",
"1432-1173"
],
"name": "Der Hautarzt",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "73"
}
],
"keywords": [
"PRP treatment",
"rich plasma injection",
"ResultsIn recent years",
"side effect treatment",
"majority of subjects",
"clinical efficacy",
"clinical trials",
"androgenetic alopecia",
"trial design",
"treatment approaches",
"methodologically weak studies",
"larger study",
"zur Behandlung",
"weak trials",
"trials",
"hair growth",
"robust data",
"effect treatment",
"plasma injection",
"positive results",
"treatment",
"current literature",
"weak studies",
"different studies",
"low levels",
"subjects",
"conclusion",
"alopecia",
"study results",
"therapy",
"concrete conclusions",
"majority",
"ConclusionThere",
"MethodsIn",
"physicians",
"study",
"Behandlung",
"efficacy",
"injection",
"optimal improvement",
"review",
"caution",
"years",
"evidence",
"current low level",
"factors",
"levels",
"data",
"differences",
"results",
"reasons",
"effect",
"improvement",
"recent years",
"brief overview",
"hope",
"combination",
"critical aspects",
"literature",
"overview",
"growth",
"aspects",
"materials",
"approach",
"address",
"design"
],
"name": "Pl\u00e4ttchenreiches Plasma (PRP) zur Behandlung der androgenetischen Alopezie (AGA): ein aktueller Literatur\u00fcberblick",
"pagination": "353-357",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1146807082"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00105-022-04979-6"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"35364687"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00105-022-04979-6",
"https://app.dimensions.ai/details/publication/pub.1146807082"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:12",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_937.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00105-022-04979-6"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00105-022-04979-6'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00105-022-04979-6'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00105-022-04979-6'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00105-022-04979-6'
This table displays all metadata directly associated to this object as RDF triples.
158 TRIPLES
21 PREDICATES
97 URIs
87 LITERALS
11 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s00105-022-04979-6 | schema:about | N594a4860d79f45838d25b5b5abed45ba |
2 | ″ | ″ | N86f64fdd182e42bf81d6d7e7f2a443b7 |
3 | ″ | ″ | N8d1e0c0c7dd94665bd186f500c6da02c |
4 | ″ | ″ | Nab680b599ef7477faf852d691ff01024 |
5 | ″ | ″ | anzsrc-for:11 |
6 | ″ | ″ | anzsrc-for:1103 |
7 | ″ | schema:author | N29cbd3af4ced47c08a126c43e866d61b |
8 | ″ | schema:citation | sg:pub.10.1007/s00403-020-02173-z |
9 | ″ | ″ | sg:pub.10.1007/s12020-017-1280-y |
10 | ″ | schema:datePublished | 2022-04-01 |
11 | ″ | schema:datePublishedReg | 2022-04-01 |
12 | ″ | schema:description | BackgroundPlatelet rich plasma (PRP) injections have been reported to be an effective and low side effect treatment for androgenetic alopecia (AGA). However, robust data concerning this therapy are lacking.AimWe address some potentially critical aspects of PRP treatment and give some reasons why study results may differ.Materials and methodsIn the following review we give a brief overview of the current literature and compare the results of the various trials.ResultsIn recent years, several clinical trials have been published that have revealed different but rather positive results, which offers hope to those affected by AGA and to physicians as well. However, the results were observed in methodologically weak trials and data from randomized controlled trials are lacking. Differences in trial designs have made it difficult to draw concrete conclusions about its clinical efficacy. Even in the studies where no hair-growth-promoting effect could be observed, the majority of subjects were at least satisfied with the result. The combination of several treatment approaches seems to lead to optimal improvement in hair growth.ConclusionThere are many factors that could have influenced the results of the different studies. The results were observed in methodologically weak studies, giving reason for caution when drawing conclusions. Nevertheless, the majority of the subjects were at least satisfied with the result. Given the current low level of evidence, PRP treatments need to be further investigated in larger studies. |
13 | ″ | schema:genre | article |
14 | ″ | schema:isAccessibleForFree | false |
15 | ″ | schema:isPartOf | N450c5220456041f3aa8225f9d3062a85 |
16 | ″ | ″ | Nd52c5b30ba6047fc8d33ab24f4416b1f |
17 | ″ | ″ | sg:journal.1327382 |
18 | ″ | schema:keywords | Behandlung |
19 | ″ | ″ | ConclusionThere |
20 | ″ | ″ | MethodsIn |
21 | ″ | ″ | PRP treatment |
22 | ″ | ″ | ResultsIn recent years |
23 | ″ | ″ | address |
24 | ″ | ″ | alopecia |
25 | ″ | ″ | androgenetic alopecia |
26 | ″ | ″ | approach |
27 | ″ | ″ | aspects |
28 | ″ | ″ | brief overview |
29 | ″ | ″ | caution |
30 | ″ | ″ | clinical efficacy |
31 | ″ | ″ | clinical trials |
32 | ″ | ″ | combination |
33 | ″ | ″ | conclusion |
34 | ″ | ″ | concrete conclusions |
35 | ″ | ″ | critical aspects |
36 | ″ | ″ | current literature |
37 | ″ | ″ | current low level |
38 | ″ | ″ | data |
39 | ″ | ″ | design |
40 | ″ | ″ | differences |
41 | ″ | ″ | different studies |
42 | ″ | ″ | effect |
43 | ″ | ″ | effect treatment |
44 | ″ | ″ | efficacy |
45 | ″ | ″ | evidence |
46 | ″ | ″ | factors |
47 | ″ | ″ | growth |
48 | ″ | ″ | hair growth |
49 | ″ | ″ | hope |
50 | ″ | ″ | improvement |
51 | ″ | ″ | injection |
52 | ″ | ″ | larger study |
53 | ″ | ″ | levels |
54 | ″ | ″ | literature |
55 | ″ | ″ | low levels |
56 | ″ | ″ | majority |
57 | ″ | ″ | majority of subjects |
58 | ″ | ″ | materials |
59 | ″ | ″ | methodologically weak studies |
60 | ″ | ″ | optimal improvement |
61 | ″ | ″ | overview |
62 | ″ | ″ | physicians |
63 | ″ | ″ | plasma injection |
64 | ″ | ″ | positive results |
65 | ″ | ″ | reasons |
66 | ″ | ″ | recent years |
67 | ″ | ″ | results |
68 | ″ | ″ | review |
69 | ″ | ″ | rich plasma injection |
70 | ″ | ″ | robust data |
71 | ″ | ″ | side effect treatment |
72 | ″ | ″ | study |
73 | ″ | ″ | study results |
74 | ″ | ″ | subjects |
75 | ″ | ″ | therapy |
76 | ″ | ″ | treatment |
77 | ″ | ″ | treatment approaches |
78 | ″ | ″ | trial design |
79 | ″ | ″ | trials |
80 | ″ | ″ | weak studies |
81 | ″ | ″ | weak trials |
82 | ″ | ″ | years |
83 | ″ | ″ | zur Behandlung |
84 | ″ | schema:name | Plättchenreiches Plasma (PRP) zur Behandlung der androgenetischen Alopezie (AGA): ein aktueller Literaturüberblick |
85 | ″ | schema:pagination | 353-357 |
86 | ″ | schema:productId | N170066db780746de96d97e54de3f58ac |
87 | ″ | ″ | N6bf068cdffd0466a8efaa685d3b43da9 |
88 | ″ | ″ | N7507db79a7ea44aaa303c29159100e20 |
89 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1146807082 |
90 | ″ | ″ | https://doi.org/10.1007/s00105-022-04979-6 |
91 | ″ | schema:sdDatePublished | 2022-08-04T17:12 |
92 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
93 | ″ | schema:sdPublisher | N530adcf565354f88bbd7462032c37636 |
94 | ″ | schema:url | https://doi.org/10.1007/s00105-022-04979-6 |
95 | ″ | sgo:license | sg:explorer/license/ |
96 | ″ | sgo:sdDataset | articles |
97 | ″ | rdf:type | schema:ScholarlyArticle |
98 | N0f2a2a26793c42a3b1580cd491142da1 | rdf:first | sg:person.01157615045.78 |
99 | ″ | rdf:rest | rdf:nil |
100 | N170066db780746de96d97e54de3f58ac | schema:name | pubmed_id |
101 | ″ | schema:value | 35364687 |
102 | ″ | rdf:type | schema:PropertyValue |
103 | N29cbd3af4ced47c08a126c43e866d61b | rdf:first | sg:person.014432353047.59 |
104 | ″ | rdf:rest | N0f2a2a26793c42a3b1580cd491142da1 |
105 | N450c5220456041f3aa8225f9d3062a85 | schema:issueNumber | 5 |
106 | ″ | rdf:type | schema:PublicationIssue |
107 | N530adcf565354f88bbd7462032c37636 | schema:name | Springer Nature - SN SciGraph project |
108 | ″ | rdf:type | schema:Organization |
109 | N594a4860d79f45838d25b5b5abed45ba | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
110 | ″ | schema:name | Treatment Outcome |
111 | ″ | rdf:type | schema:DefinedTerm |
112 | N6bf068cdffd0466a8efaa685d3b43da9 | schema:name | doi |
113 | ″ | schema:value | 10.1007/s00105-022-04979-6 |
114 | ″ | rdf:type | schema:PropertyValue |
115 | N7507db79a7ea44aaa303c29159100e20 | schema:name | dimensions_id |
116 | ″ | schema:value | pub.1146807082 |
117 | ″ | rdf:type | schema:PropertyValue |
118 | N86f64fdd182e42bf81d6d7e7f2a443b7 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
119 | ″ | schema:name | Humans |
120 | ″ | rdf:type | schema:DefinedTerm |
121 | N8d1e0c0c7dd94665bd186f500c6da02c | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
122 | ″ | schema:name | Platelet-Rich Plasma |
123 | ″ | rdf:type | schema:DefinedTerm |
124 | Nab680b599ef7477faf852d691ff01024 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
125 | ″ | schema:name | Alopecia |
126 | ″ | rdf:type | schema:DefinedTerm |
127 | Nd52c5b30ba6047fc8d33ab24f4416b1f | schema:volumeNumber | 73 |
128 | ″ | rdf:type | schema:PublicationVolume |
129 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
130 | ″ | schema:name | Medical and Health Sciences |
131 | ″ | rdf:type | schema:DefinedTerm |
132 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
133 | ″ | schema:name | Clinical Sciences |
134 | ″ | rdf:type | schema:DefinedTerm |
135 | sg:journal.1327382 | schema:issn | 0017-8470 |
136 | ″ | ″ | 1432-1173 |
137 | ″ | schema:name | Der Hautarzt |
138 | ″ | schema:publisher | Springer Nature |
139 | ″ | rdf:type | schema:Periodical |
140 | sg:person.01157615045.78 | schema:affiliation | grid-institutes:grid.411580.9 |
141 | ″ | schema:familyName | Kopera |
142 | ″ | schema:givenName | D. |
143 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157615045.78 |
144 | ″ | rdf:type | schema:Person |
145 | sg:person.014432353047.59 | schema:affiliation | grid-institutes:grid.411580.9 |
146 | ″ | schema:familyName | Gressenberger |
147 | ″ | schema:givenName | P. |
148 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014432353047.59 |
149 | ″ | rdf:type | schema:Person |
150 | sg:pub.10.1007/s00403-020-02173-z | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1134505309 |
151 | ″ | ″ | https://doi.org/10.1007/s00403-020-02173-z |
152 | ″ | rdf:type | schema:CreativeWork |
153 | sg:pub.10.1007/s12020-017-1280-y | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1084033726 |
154 | ″ | ″ | https://doi.org/10.1007/s12020-017-1280-y |
155 | ″ | rdf:type | schema:CreativeWork |
156 | grid-institutes:grid.411580.9 | schema:alternateName | Universitätsklinik für Dermatologie und Venerologie, Medizinische Universität Graz, Auenbruggerplatz 8, 8036, Graz, Österreich |
157 | ″ | schema:name | Universitätsklinik für Dermatologie und Venerologie, Medizinische Universität Graz, Auenbruggerplatz 8, 8036, Graz, Österreich |
158 | ″ | rdf:type | schema:Organization |